Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 2/20 | 0.61 |
| ▸ | SRC | P12931 | 1/20 | 0.61 |
| ▸ | HTR2A | P28223 | 7/20 | 0.54 |
| ▸ | HTR2C | P28335 | 6/20 | 0.54 |
| ▸ | CNR1 | P21554 | 1/20 | 0.51 |
| ▸ | FNTA | P49354 | 1/20 | 0.51 |
| ▸ | FNTB | P49356 | 1/20 | 0.51 |
| ▸ | DRD2 | P14416 | 3/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28405021 | 0.87 | EGFR (0.55) | EGFRSRCHTR2AHTR2CDRD2 | |
| SCHEMBL28156096 | 0.83 | EGFR (0.63) | EGFRHTR2AHTR2CCNR1FNTA | |
| SCHEMBL28906516 | 0.80 | HTR2A (0.62) | HTR2AHTR2CCNR1DRD2ESR1 | |
| SCHEMBL6669255 | 0.79 | EGFR (0.56) | EGFRSRCHTR2AHTR2CFNTA | |
| SCHEMBL1777136 | 0.79 | CLK1 (0.49) | EGFRSRCCNR1FNTAFNTB | |
| SCHEMBL18301165 | 0.77 | EGFR (0.63) | EGFRSRCHTR2AHTR2CFNTA | |
| SCHEMBL6669729 | 0.77 | EGFR (0.63) | EGFRSRCHTR2AHTR2CFNTA | |
| SCHEMBL29915686 | 0.77 | EGFR (0.63) | EGFRSRC | |
| SCHEMBL7127234 | 0.77 | EGFR (0.63) | EGFRSRC | |
| SCHEMBL12877452 | 0.77 | HTR2A (0.64) | HTR2AHTR2CCNR1DRD2ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111251500-B | Foaming polymer particles with skin dilatancy and preparation method thereof | 厦门天策材料科技有限公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-111253583-B | Dilatant hybrid dynamic polymer and dilatant realization method thereof | 厦门天策材料科技有限公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-111040110-B | Force-induced response dynamic polymer and application thereof | 厦门天策材料科技有限公司 | 2022-03-11 | — | — | CN | disclosed |
| CN-113997650-A | Multilayer structure assembly with force-induced responsiveness | 厦门天策材料科技有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-114001114-A | Flexible energy absorption system with concave corner structure | 厦门天策材料科技有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-113980335-A | 3D printing dilatancy energy-absorbing structure and preparation method thereof | 厦门天策材料科技有限公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-113978071-A | Multilayer structure assembly | 翁秋梅 | 2022-01-28 | — | — | CN | disclosed |
| CN-111378159-A | Energy absorption method and material based on hybrid cross-linked dynamic polymer | 翁秋梅 | 2020-07-07 | — | — | CN | disclosed |
| CN-111378160-A | Combined energy absorption method and application thereof | 翁秋梅 | 2020-07-07 | — | — | CN | disclosed |
| CN-111378138-A | Combined energy absorption method and application thereof | 翁秋梅 | 2020-07-07 | — | — | CN | disclosed |
| CN-111150196-A | Electronic device package containing dilatant component | 翁秋梅 | 2020-05-15 | — | — | CN | disclosed |
| CN-111150173-A | Shock attenuation sole and shock attenuation shoes | 翁秋梅 | 2020-05-15 | — | — | CN | disclosed |
| CN-111040110-A | Force-induced response dynamic polymer and application thereof | 翁秋梅 | 2020-04-21 | — | — | CN | disclosed |
| CN-111040202-A | Combined hybrid dynamic polymer and application thereof | 翁秋梅 | 2020-04-21 | — | — | CN | disclosed |
| CN-101687789-A | Novel inhibitors hepatitis c virus replication | INTERMUNE INC | 2010-03-31 | — | — | CN | disclosed |
| EP-2134683-A2 | NOVEL INHIBITORS HEPATITIS C VIRUS REPLICATION | Intermune, Inc. (US) | 2009-12-23 | — | — | EP | disclosed |
| US-20090047246-A1 | NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION | INTERMUNE, INC. (US) | 2009-02-19 | — | — | US | disclosed |
| WO-2008100867-A2 | NOVEL INHIBITORS HEPATITIS C VIRUS REPLICATION | INTERMUNE, INC. (US) | 2008-08-21 | — | — | WO | disclosed |
| US-7388100-B2 | Tertiary amine compounds | NISHIO TETSUYA | 2008-06-17 | — | — | US | disclosed |
| US-20060145145-A1 | Tertiary amine compounds, organic semiconductor devices using the same and organic electroluminescence devices using the same | NISHIO TETSUYA | 2006-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060145145-A1 | Tertiary amine compounds, organic semiconductor devices using the same and organic electroluminescence devices using the same | PIEZO1, YES1, SAT1 | EGFR 3523/4885SRC 1608/4885HTR2A 1111/4885 |
| US-20090047246-A1 | NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION | EIF2AK2, HAVCR2, HCCS | EGFR 913/4885SRC 648/4885HTR2A 3961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.